Daflon is named as an intervention in 4 current clinical trials in our Egypt and India registers. 4 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Keri Pharma Hungary Kft (1). The most-studied condition is Healthy Volunteers.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection
NCT06546111 · ClinicalTrials.gov ↗ · Helicobacter Pylori Infection
|
Phase 1/2 | Recruiting | Sadat City University | Egypt |
|
Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study
NCT07674446 · ClinicalTrials.gov ↗ · Healthy Volunteers
|
Phase 1 | Recruiting | Keri Pharma Hungary Kft | India |
|
Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome
NCT06560294 · ClinicalTrials.gov ↗ · Glue Embolization, Pelvic Congestion Syndrome
|
Not applicable | Recruiting | Tanta University | Egypt |
|
Silymarin vs Hesperidin/Diosmin in Fibromyalgia
NCT07293767 · ClinicalTrials.gov ↗ · Fibromyalgia (FM)
|
Not applicable | Recruiting | Ain Shams University | Egypt |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Keri Pharma Hungary Kft | 1 |
| Tanta University | 1 |
| Ain Shams University | 1 |
| Sadat City University | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Egypt | 3 | 3 |
| Clinical trials in India | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
4 current trials in our Egypt and India registers name Daflon as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 4 of the 4 trials are recruiting: 3 with sites in Egypt and 1 with sites in India. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Keri Pharma Hungary Kft (1), Tanta University (1), Ain Shams University (1) and Sadat City University (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Daflon works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Daflon works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Daflon (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.